Total Other Income - Cyteir Therapeutics Inc (NASDAQ:CYT) - Alpha Spread

Watchlist Manager

Watchlist

Price: 3.02 USD -2.27%

Updated:

Cyteir Therapeutics Inc
Total Other Income

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Cyteir Therapeutics Inc
Total Other Income Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Total Other Income	CAGR 3Y	CAGR 5Y	CAGR 10Y
C	Cyteir Therapeutics Inc NASDAQ:CYT	Total Other Income $2.1m	CAGR 3-Years 104%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Total Other Income -$3.5B	CAGR 3-Years 12%	CAGR 5-Years -62%	CAGR 10-Years -78%
	Gilead Sciences Inc NASDAQ:GILD	Total Other Income $158m	CAGR 3-Years 4%	CAGR 5-Years -23%	CAGR 10-Years N/A
	Amgen Inc NASDAQ:AMGN	Total Other Income $151m	CAGR 3-Years 126%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Total Other Income -$55.2m	CAGR 3-Years N/A	CAGR 5-Years 1%	CAGR 10-Years N/A
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Total Other Income -$31.6m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2022, Cyteir Therapeutics Inc's Total Other Income amounts to 2.1m USD.

Over the last year, the Total Other Income growth was 1 523%. The average annual Total Other Income growth rates for Cyteir Therapeutics Inc have been 104% over the past three years .

Join more than 138,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.